These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 11969409)

  • 21. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.
    Chen KX; Njoroge FG; Arasappan A; Venkatraman S; Vibulbhan B; Yang W; Parekh TN; Pichardo J; Prongay A; Cheng KC; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
    J Med Chem; 2006 Feb; 49(3):995-1005. PubMed ID: 16451065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibiting viral proteases: challenges and opportunities.
    Bianchi E; Pessi A
    Biopolymers; 2002; 66(2):101-14. PubMed ID: 12325160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3.4A serine protease.
    Lin C; Kwong AD; Perni RB
    Infect Disord Drug Targets; 2006 Mar; 6(1):3-16. PubMed ID: 16787300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor.
    McCauley JA; McIntyre CJ; Rudd MT; Nguyen KT; Romano JJ; Butcher JW; Gilbert KF; Bush KJ; Holloway MK; Swestock J; Wan BL; Carroll SS; DiMuzio JM; Graham DJ; Ludmerer SW; Mao SS; Stahlhut MW; Fandozzi CM; Trainor N; Olsen DB; Vacca JP; Liverton NJ
    J Med Chem; 2010 Mar; 53(6):2443-63. PubMed ID: 20163176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
    De Francesco R; Pessi A; Steinkühler C
    Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-ketoacids are potent slow binding inhibitors of the hepatitis C virus NS3 protease.
    Narjes F; Brunetti M; Colarusso S; Gerlach B; Koch U; Biasiol G; Fattori D; De Francesco R; Matassa VG; Steinkühler C
    Biochemistry; 2000 Feb; 39(7):1849-61. PubMed ID: 10677236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic.
    Tsantrizos YS
    Biopolymers; 2004; 76(4):309-23. PubMed ID: 15386268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Azapeptides as inhibitors of the hepatitis C virus NS3 serine protease.
    Zhang R; Durkin JP; Windsor WT
    Bioorg Med Chem Lett; 2002 Apr; 12(7):1005-8. PubMed ID: 11909704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus NS3/4A protease.
    Kwong AD; Kim JL; Rao G; Lipovsek D; Raybuck SA
    Antiviral Res; 1998 Dec; 40(1-2):1-18. PubMed ID: 9864043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography.
    Sudo K; Inoue H; Shimizu Y; Yamaji K; Konno K; Shigeta S; Kaneko T; Yokota T; Shimotohno K
    Antiviral Res; 1996 Aug; 32(1):9-18. PubMed ID: 8863991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel high throughput screening assay for HCV NS3 serine protease inhibitors.
    Berdichevsky Y; Zemel R; Bachmatov L; Abramovich A; Koren R; Sathiyamoorthy P; Golan-Goldhirsh A; Tur-Kaspa R; Benhar I
    J Virol Methods; 2003 Feb; 107(2):245-55. PubMed ID: 12505640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Product inhibition of the hepatitis C virus NS3 protease.
    Steinkühler C; Biasiol G; Brunetti M; Urbani A; Koch U; Cortese R; Pessi A; De Francesco R
    Biochemistry; 1998 Jun; 37(25):8899-905. PubMed ID: 9636031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors.
    Llinàs-Brunet M; Bailey M; Fazal G; Ghiro E; Gorys V; Goulet S; Halmos T; Maurice R; Poirier M; Poupart MA; Rancourt J; Thibeault D; Wernic D; Lamarre D
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2267-70. PubMed ID: 11055335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus.
    Morikawa K; Lange CM; Gouttenoire J; Meylan E; Brass V; Penin F; Moradpour D
    J Viral Hepat; 2011 May; 18(5):305-15. PubMed ID: 21470343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-peptidic small-molecule inhibitors of the single-chain hepatitis C virus NS3 protease/NS4A cofactor complex discovered by structure-based NMR screening.
    Wyss DF; Arasappan A; Senior MM; Wang YS; Beyer BM; Njoroge FG; McCoy MA
    J Med Chem; 2004 May; 47(10):2486-98. PubMed ID: 15115392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitors of hepatitis C virus NS3.4A protease. Part 3: P2 proline variants.
    Perni RB; Farmer LJ; Cottrell KM; Court JJ; Courtney LF; Deininger DD; Gates CA; Harbeson SL; Kim JL; Lin C; Lin K; Luong YP; Maxwell JP; Murcko MA; Pitlik J; Rao BG; Schairer WC; Tung RD; Van Drie JH; Wilson K; Thomson JA
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1939-42. PubMed ID: 15050632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227).
    Seiwert SD; Andrews SW; Jiang Y; Serebryany V; Tan H; Kossen K; Rajagopalan PT; Misialek S; Stevens SK; Stoycheva A; Hong J; Lim SR; Qin X; Rieger R; Condroski KR; Zhang H; Do MG; Lemieux C; Hingorani GP; Hartley DP; Josey JA; Pan L; Beigelman L; Blatt LM
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4432-41. PubMed ID: 18824605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domain.
    LaPlante SR; Aubry N; Bonneau PR; Kukolj G; Lamarre D; Lefebvre S; Li H; Llinàs-Brunet M; Plouffe C; Cameron DR
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2271-4. PubMed ID: 11055336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide-β-lactam Inhibitors of Dengue and West Nile Virus NS2B-NS3 Protease Display Two Distinct Binding Modes.
    Dražić T; Kopf S; Corridan J; Leuthold MM; Bertoša B; Klein CD
    J Med Chem; 2020 Jan; 63(1):140-156. PubMed ID: 31804823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel 2-oxoimidazolidine-4-carboxylic acid derivatives as hepatitis C virus NS3-4A serine protease inhibitors: synthesis, activity, and X-ray crystal structure of an enzyme inhibitor complex.
    Arasappan A; Njoroge FG; Parekh TN; Yang X; Pichardo J; Butkiewicz N; Prongay A; Yao N; Girijavallabhan V
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5751-5. PubMed ID: 15501035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.